Sequana Medical NV
SQNMF
$1.22
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 56.80K | 114.10K | 290.70K | 469.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 56.80K | 114.10K | 290.70K | 469.20K |
| Cost of Revenue | 400.00 | 14.40K | 28.60K | 69.10K | 110.10K |
| Gross Profit | -400.00 | 42.30K | 85.40K | 221.40K | 358.90K |
| SG&A Expenses | 17.90M | 18.01M | 18.50M | 20.65M | 22.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 154.10K | 154.10K | 154.10K | 191.10K | 227.10K |
| Total Operating Expenses | 19.67M | 19.88M | 20.50M | 23.40M | 26.23M |
| Operating Income | -19.67M | -19.82M | -20.39M | -23.11M | -25.76M |
| Income Before Tax | -56.06M | -51.64M | -48.02M | -38.75M | -29.02M |
| Income Tax Expenses | 283.90K | 290.70K | 303.30K | 344.80K | 385.20K |
| Earnings from Continuing Operations | -56.34 | -51.93 | -48.33 | -39.10 | -29.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.34M | -51.93M | -48.33M | -39.10M | -29.40M |
| EBIT | -19.67M | -19.82M | -20.39M | -23.11M | -25.76M |
| EBITDA | -18.87M | -19.27M | -20.06M | -22.76M | -25.38M |
| EPS Basic | -1.26 | -1.25 | -1.25 | -1.13 | -0.99 |
| Normalized Basic EPS | -0.79 | -0.78 | -0.78 | -0.70 | -0.61 |
| EPS Diluted | -1.26 | -1.25 | -1.25 | -1.13 | -0.99 |
| Normalized Diluted EPS | -0.79 | -0.78 | -0.78 | -0.70 | -0.61 |
| Average Basic Shares Outstanding | 187.13M | 167.07M | 147.00M | 134.09M | 121.18M |
| Average Diluted Shares Outstanding | 187.13M | 167.07M | 147.00M | 134.09M | 121.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |